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To quantitatively determine tylosin and tilmicosin in edible animal tissues, a time-resolved fluoroimmunoassay (TRFIA) has been 
developed and validated. For this purpose, desmycosin-O-carboxymethoxylamine-BSA was fixed onto microtiter plates, standards 
and samples were loaded and, finally, diluted europium-labeled anti-tylosin antibodies were added. Results show that the limit of 
detection for tylosin was 0.03 ng mL−1 and that for tilmicosin was 0.05 ng mL−1. The recoveries were 73.6% to 120.5%, with co-
efficients of variation below 15.6% in various biological matrices spiked with tylosin and tilmicosin at concentrations of 50–200 
ng g−1. There was good correlation (R2>0.99) between the TRFIA, an enzyme-linked immunosorbent assay and high performance 
liquid chromatography data. In conclusion, the new TRFIA is applicable to the detection of tylosin and tilmicosin and is an effec-
tive and economical method that will enable high-throughput sample screening. The method is expected to be widely applicable. 
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Tylosin, a macrolide antibiotic, is extensively applied in 
veterinary medicine because it is strongly resistant to most 
of Gram-positive and -negative bacteria, as well as Myco-
plasma spp. and Chlamydia spp. [1]. Tilmicosin, (20-deoxo- 
20-(3,5-dimethyl-piperidin-1-yl)-desmycosin, is a semisyn-
thetic macrolide antibiotic with a spectrum of microbiolog-
ical activity against Pasteurella spp., Mycoplasma spp., and 
a variety of Gram-positive organisms [2]. For these reasons, 
tylosin and tilmicosin are widely employed to treat a broad 
range of infections in domestic animals, especially respira-
tory diseases. The residues of these antibiotics may stay in 
the edible tissue of animals when misused, which may trig-
ger allergies and select for resistance. Therefore, the use of 
tylosin and tilmicosin in feed additives was banned in the 
European Union in 1999 [3]. Within China, maximum resi-
due limits (MRLs) have also been established for tylosin 
and tilmicosin. Therefore, there is a need to develop a sim-
ple and efficient detection method to screen tylosin and 
tilmicosin antibiotics in food producing animals.  
For animal product safety control, several detection 
methods for tylosin and tilmicosin residues have been de-
veloped in recent years, including high performance liquid 
chromatography (HPLC) [4–8], thin-layer chromatography 
[9], HPLC coupled with mass spectrometry [10–15], and 
microbiological assays [4,16]. However, expensive equip-
ment, skilled technicians and complicated sample pretreat-
ments are required for those methods, making them unsuit-
able for high throughput field detection or routine screening. 
The microbiological assay is lengthy and insufficiently spe-
cific for analytical purposes. Immunoassays are valuable as 
rapid, low cost and high throughput tests for rapid screening 
of a large number of samples. A number of researchers have 
established enzyme-linked immunosorbent assays (ELISAs) 
for tylosin and tilmicosin [1,17–20]. ELISA is used fre-
quently because it is highly sensitive, portable and suitable 
for large-scale use but it is imprecise and positively biased 
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because of matrix effects [21,22]. 
A highly sensitive, dual-label, time-resolved fluoroim-
munoassay (TRFIA) that can simultaneously detect tylosin 
and tilmicosin is described in this paper, which offers ad-
vantages of cost and time efficiency, allowing simplified 
assay protocols and small sample volumes [22]. Because of 
the unique fluorescent properties of lanthanide chelates, 
which have the advantages of high quantum yields, nar-
rowband emission peaks, long Stoke’s shifts and fluores-
cence lifetimes, TRFIA is distinct from conventional fluo-
rescent dyes. The half-life of background fluorescence is 
very short so the long duration of lanthanide chelate emis-
sion allows longer measurement, which distinguishes spe-
cific fluorescence from the background. Thus, the sensitivi-
ty of a TRFIA is higher than that of conventional methods, 
which lessens the susceptibility of the TRFIA to matrix in-
terference [21,23]. 
This is the first report describing an Eu3+ fluorescent 
lanthanides-based TRFIA with high sensitivity and cost- 
efficiency for detection of tylosin and tilmicosin in edible 
tissues of food-producing animals. Comparisons are made 
between the TRFIA and conventional HPLC and ELISA 
methods. Finally, TRFIA was validated by analysis of swine 
muscle and liver samples. 
1  Materials and methods 
1.1  Materials and reagents  
Tylosin, tilmicosin, desmycosin (DES), O-carboxymethox- 
ylamine hemihydrochloride (CMO), spiramycin, erythromy-
cin, kitasamycin, azithromycin, josamycin, oleandomycin, 
roxithromycin, avermectin, ivermectin, ovalbumin (OVA), 
and bovine serum albumin  (BSA) were purchased from 
Sigma (St. Louis, MO, USA). N′-[p-Isothiocyanatobenzyl]- 
diethylene-triamineN1,N2,N3,N4-tetraacetate-Eu3+(DTTA-Eu3+) 
was from the Tianjin Radio-Medical Institute (Tianjin, 
China). Anti-tylosin monoclonal antibody (anti-tylosin 
MAb), DES-CMO-BSA and DES-CMO-OVA were ob-
tained from Huazhong Agricultural University (Wuhan, 
China). A mouse monoclonal antibody isotyping kit was 
purchased from Southern Biotech Co. (Beijing, China). Se-
phadex 6B and G-50 were obtained from Pharmacia (Upp-
sala, Sweden). Buffers were prepared in our laboratory. All 
chemicals and reagents were of analytical grade or better, 
and the percentage concentrations are reported by weight 
unless otherwise specified. 
1.2  Labeling of MAb with europium chelate 
Europium-labeled MAbs (tracers) were prepared as de-
scribed in the literature [24]. Briefly, 1 mg anti-tylosin MAb 
and 1 mg DTTA-Eu3+ were mixed in 50 mmol L−1 sodium 
carbonate buffer (pH 9.6) in an amber bottle and then kept 
at 4°C with stirring for over 24 h. The mixture was purified 
by a Sephadex 6B/G-50 column and 0.1% (w/v) BSA was 
added to the collected MAb-DTTA-Eu3+. This mixture of 
MAb-DTTA-Eu3+ and BSA was ready for use and can be 
preserved for one year when stored at −20°C. 
1.3  Pre-treatment of samples 
Samples, such as porcine muscles, porcine liver, chicken 
muscle, chicken liver and fish, obtained at a local super-
market, were analyzed by HPLC for the tylosin and 
tilmicosin contents. The negative control was samples 
without tylosin and tilmicosin contamination, as identified 
by an HPLC test. The sample (2 ± 0.005) g was homoge-
nized, mixed with 4 mL ethyl acetate, followed by 2 min 
vortexing and then 10 min centrifugation at 2000 r min−1. 
The supernatant was gathered and 4 mL ethyl acetate was 
added to the pellet and the above treatment was repeated. 
The supernatant was evaporated in a water bath under a 
gentle nitrogen flow at 60°C. The extractions were resus-
pended in 1 mL of 10 mmol L−1 PBS (pH 7.4) and mixed 
thoroughly before TRFIA and ELISA analysis. The samples 
were pretreated for HPLC analysis, as described previously 
[25]. 
1.4  The competitive TRFIA 
The 96-well Maxisorp microtiter plates (Nunc, Roskilde, 
Denmark) were coated overnight with conjugates (DES- 
CMO-BSA, 1 mg L−1) diluted in carbonate buffer (50 mmol 
L−1, pH 9.6), followed by blocking for 2 h at 37°C with a 
blocking buffer (50 mmol/L Tris-HCl, pH 8.0, containing 
0.9% NaCl, 0.5% BSA, 0.4% stabilizing reagent, and 0.04% 
NaN3). The plate was then washed three times with a wash-
ing buffer (10 mmol L−1 Tris-HCl, pH 8.0, containing 0.9% 
NaCl and 0.1% Tween 20). Subsequently, 50 μL standard 
solutions or samples and 50 μL europium-labeled MAbs 
diluted with assay buffer were added to the plates. After 
incubation at 37°C for 1 h, the plates were washed six times, 
and an enhancement solution (0.1 mol L−1 potassium biph-
thalate-acetic acid buffer containing 15 μmol L−1 β-naph- 
thoyltrifluoroacetone and 0.1% (w/v) Triton X-100) was 
added to each well. The plates were then shaken for 5 min 
for reaction and then rested for 10 min. The fluorescence 
was measured using a VICTOR2 multilabel counter (Perki-
nElmer Wallac, Turku, Finland) at excitation wavelength 
340 nm and emission wavelength 615 nm, with a delay time 
of 400 μs. The tylosin and tilmicosin contents in the sam-
ples were calculated from standard curves. The half-maxi- 
mal inhibition concentration (IC50) was determined as a 
measure of the sensitivity of the TRFIA. 
1.5  Comparison of the TRFIA with ELISA and HPLC 
To further demonstrate the capability and accuracy of the 
TRFIA, a comparison between TRFIA, ELISA and HPLC 
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was conducted using samples (liver and muscle) from an 
animal-feeding experiment. Duroc castrated pigs with 
weights of 13–15 kg were kept separately in an animal fa-
cility for one week. Eight pigs were randomly divided into 
control and test groups. The control group (n = 1) was under 
mock intramuscular treatment with another drug. The test 
group (n = 3) was treated by tylosin intramuscularly at a 
dose of bodyweight (BW) 10 mg kg−1 daily for 5 continuous 
days. The animals were euthanized at days 0, 1, and 3 of 
withdrawal after tylosin treatments. The muscle and liver 
samples were collected separately and stored at −20°C until 
analysis by TRFIA, ELISA and HPLC.  
2  Results and discussion 
2.1  Preparation of optimum working solutions for  
antibodies 
Tylosin or tilmicosin in a series of dilutions were added to 
the coated plate. As shown in Figure 1, the anti-tylosin 
MAb solutions diluted at 1:4000–1:10000 produced inhib-
itory rates of 50%–30%. The working concentration for the 
anti-tylosin MAb was 1:5000. 
2.2  Cross-reactivities of MAb 
The cross-reactivities between tilmicosin, tylosin, and their 
structural analogues (desmycosin, 5-O-mycaminosylty- 
lonolide, spiramycin, erythromycin, kitasamycin, azithro-
mycin, josamycin, oleandomycin, roxithromycin, avermec-
tin, ivermectin) were tested to assess specificity. As shown 
in Table 1, the MAb showed cross-reactivity towards tylo-
sin (100%), tilmicosin (51%), desmycosin (176%), and 
5-O-mycaminosyltylonolide (4.5%), but did not generate 
significant cross-reactivity (<0.1) with the other antibiotics 
listed above. Thus, the TRFIA could be employed as a 
screening method for multiresidue detection. 
2.3  The standard curve for the TRFIA  
The optimum conditions for TRFIA were a coating antigen  
 
 
Figure 1  Dilution curve of MAb by TRFIA.  
Table 1  Cross-reactivity of macrolide antibiotics by the TRFIA based on 
MAb 
Competitor IC50 (ng mL
−1) Cross-reactivity (%) 
Tylosin 0.98 100 
Tilmicosin 1.92 51 
Desmycosin 0.56 176 
5-O-mycaminosyltylonolide 21.78 4.5 
Spiramycin >1000 <0.1 
Erythromycin >1000 <0.1 
Kitasamycin >1000 <0.1 
Azithromycin >1000 <0.1 
Josamycin >1000 <0.1 
Oleandomycin >1000 <0.1 
Roxithromycin >1000 <0.1 
Avermectin >1000 <0.1 
Ivermectin >1000 <0.1 
 
 
(DES-CMO-OVA) concentration of 1 mg L–1 and a MAb 
dilution ratio of 1:8000, which generated an optimal linear 
portion of the response curve. These conditions were 
adopted for subsequent experiments. The standard curves 
plotted by TRFIA analysis showed that the working concen-
tration ranged from 0.01 to 100 ng mL–1 (Figure 2). Good 
linearity was obtained in the range of 0.08 to 25 ng mL–1, 
with acceptable correlation coefficients (R2=96.83%– 
99.19%). With regard to assay sensitivity, IC50 values were 
calculated to be 0.89 and 1.73 ng mL–1 for tylosin and 
tilmicosin, respectively. The limit of detection (LOD) was 
expressed as mean + 3 × standard deviations [22]. Blank 
samples were determined by repeated analysis (n = 20) of 
tylosin/tilmicosin-free samples. The LODs of the TRFIA for 
tylosin and tilmicosin were 0.03 and 0.05 ng mL–1, respec-
tively. The definition for limit of quantification (LOQ) was 
the tylosin/tilmicosin concentration of samples with a B/B0 
ratio of approximately 0.8 and coefficient of variation (CV) 
less than 20% [22]. The LOQ for tylosin was 0.07 ng mL–1, 
with CVs of 4.7, while the LOQ for tilmicosin was 0.11  
ng mL–1, with CVs of 5.3.  
 
 
Figure 2  Calibration curve of tylosin/tilmicosin TRFIA.  
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2.4  Recovery and reliability of the TRFIA assay 
The MRL for tylosin or tilmicosin is 100 ng g−1 in muscle 
and liver and 50 ng g−1 in egg [1]. The recoveries and re-
peatability of various biological matrices spiked with tylo-
sin or tilmicosin at levels of 0.5 × MRL, 1 × MRL, and 2 × 
MRL are listed in Table 2. Close correlations were obtained 
between the measured values and the fortified concentra-
tions at the three spiked levels. The recovery for tylosin 
ranged between 73.6% and 108.5% and that for tilmicosin 
ranged between 75.1% and 120.5%. The repeatability of the 
assay was validated by calculating CVs, which were less 
than 15.6%. 
2.5  Comparison between TRFIA, ELISA and HPLC 
Table 3 displays a summary of the results from TRFIA, 
HPLC and ELISA analyses, which reveals that 1–3 with-
drawal days were needed for the attenuation of drug con-
centration to the MRLs levels (100 ng g–1) in both swine 
muscle and liver. For quantitative analyses, TRFIA, ELISA 
and HPLC methods showed good correlation coeficients 
(R2>0.99) in a side-by-side comparison. However, the 
TRFIA results are closer to HPLC results than to ELISA 
results for positive tylosin samples collected intraday and at 
the first day of withdrawal.  
3  Conclusions 
In this study, a simple and efficient TRFIA method has been 
established, which enables the analysis of tylosin and 
tilmicosin in edible animal tissues. The TRFIA method with 
europium tracer has a significantly increased sensitivity 
compared with the conventional ELISA. To validate the 
new method, comparisons were made between TRFIA, 
HPLC and ELISA in animal experiments, by which good 
correlations (R2 > 0.99) were obtained and the new method 
was validated. The detection limits, CVs, and recoveries 
satisfy the standards of the USA, EU, Canada, and China. 
Therefore, the new TRFIA described here is a rapid, accu-
rate, and economical method for detecting tylosin, 
tilmicosin and their metabolites, simultaneously, in animal 
tissues. 
 
Table 2  Recoveries of tylosin and tilmicosin spiked in tissues by the TRFIA (n = 15) a) 
Sample Spiked level (ng g−1) 
Tylosin Tilmicosin 
Mean recovery (ng g−1) CV (%) Mean recovery (ng g−1) CV (%) 
Porcine muscle 50 94.6 9.6 88.7 12.5 
 
100 73.6 5.3 108.7 15.6 
200 95.3 4.8 112.5 7.9 
Porcine liver 50 103.7 12.4 95.4 11.3 
 
100 79.4 10.3 106.8 10.8 
200 86.5 8.4 112.1 15.3 
Chicken 50 87.4 7.5 85.3 9.7 
 
100 97.6 4.7 99.8 11.6 
200 78.2 13.2 76.2 10.7 
Chicken liver 50 102.6 10.6 93.2 14.8 
 
100 84.2 6.4 75.1 8.6 
200 108.5 5.9 84.9 5.6 
Fish 25 96.3 9.7 100.8 12.8 
 
50 79.2 11.6 120.5 7.3 
100 88.3 10.5 96.3 13.5 
a) The test was repeated three times with five replicates per concentration. 
Table 3  Result analyses of HPLC, ELISA and TRFIA, for the detection of tylosin in swine muscle and liver samples from animal experiments (mean ± SD, 
n = 5)a) 
Withdrawals (d) Samples HPLC (ng g–1) ELISA (ng g–1) TRFIA (ng g–1) 
0 Muscle 186.4 ± 13.8 172.9 ± 23.5 185.2 ± 9.3 
 Liver 487.5 ± 48.6 448.3 ± 50.4 485.6 ± 27.6 
1 Muscle 78.3 ± 13.8 67.5 ± 4.2 77.9 ± 10.5 
 Liver 136.2 ± 15.2 119.7 ± 16.2 132.2 ± 10.6 
3 Muscle <50 <20 18.7 ± 4.3 
 Liver 61.4 ± 9.7 53.2 ± 12.8 61.8 ± 6.5 
a) SD means of standard deviation. LOD of tylosin by HPLC method was 50 ng g–1. 
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